Low Levels of Th1-Type Cytokines and Increased Levels of Th2-Type Cytokines in Kidney Transplant Recipients With Active Cytomegalovirus Infection

Transplantation Proceedings

Volumn 41, Issue 5, 2009, Pages 1643-1647

  Essa, S ^a   Pacsa, A ^a   Raghupathy, R ^a   Said, T ^a   Nampoory, M R N ^a   Johny, K V ^a   Al Nakib, W ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; PROTEIN ANTIGEN GB; PROTEIN ANTIGEN PP150; PROTEIN ANTIGEN PP28; PROTEIN ANTIGEN PP38; PROTEIN ANTIGEN PP65; THYMIDINE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CYTOKINE PRODUCTION; CYTOMEGALOVIRUS INFECTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GRAFT RECIPIENT; HUMAN; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TH1 CELL; TH2 CELL;

ADULT; ANTIGENS, VIRAL; CYTOKINES; CYTOMEGALOVIRUS INFECTIONS; FEMALE; HUMANS; KIDNEY TRANSPLANTATION; MALE; TH1 CELLS; TH2 CELLS; VIREMIA;

EID: 67449161071     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2008.10.098     Document Type: Article

References (22)

1. Rubin R.H. Impact of cytomegalovirus infection on organ transplant recipients. Rev Infect Dis 12 (1990) S754
2. Jonjic S., Pavic I., Plic B., et al. Antibodies are not essential for the resolution of primary cytomegalovirus infection but limit dissemination of recurrent virus. J Exp Med 179 (1994) 1713
3. Essa S., Raghupathy R., Pacsa A.S., et al. Th1-type cytokines production is decreased in kidney transplant recipients with active cytomegalovirus infection. J Med Virol 60 (2000) 223
4. Romagnani S. Lymphokine production by human T cells in disease states. Ann Rev Immunol 12 (1994) 227
5. Mosmann T.R., and Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 17 (1996) 138
6. Clerici M., and Shearer G.M. A Th1→Th2 switch is a critical step in the etiology of HIV infection. Immunol Today 14 (1993) 107
7. Gazzinelli R.T., Makino M., Chattopadhyay S.K., et al. CD4+ subset regulation in viral infection. Preferential activation of Th2 cells during progression of retrovirus-induced immunodeficiency in mice. J Immunol 148 (1992) 182
8. Actor J.K., Marshall M.A., Eltoum I.A., et al. Increased susceptibility of mice infected with Shistosoma mansoni to recombinant vaccinia virus. Eur J Immunol 24 (1994) 3050
9. Jayaraman S., Heiligenhaus A., Rodriguez A., et al. Exacerbation of murine herpes simplex virus-mediated stromal keratitis by Th2 type T cells. J Immunol 151 (1993) 5777
10. Chaturvedi U.C., Elbishbishi E.A., Agarwal R., et al. Sequential production of cytokines by dengue virus-infected human peripheral blood leukocyte cultures. J Med Virol 59 (1999) 335
11. + T helper type 2 T lymphocytes do not promote recovery from experimental virus infection. J Exp Med 180 (1994) 1273
12. Alp N.J., Allport T.D., VanZanten J., et al. Fine specificity of cellular immune responses in human to human cytomegalovirus immediate-early 1 protein. J Virol 65 (1991) 4812
13. Curtsinger J.M., Liu Y.C., Radeke R., et al. Molecular analysis of the immune response to human cytomegalovirus glycoprotein B (gB). II. Low gB-specific T and B cell responses are associated with expression of certain HLA-DR alleles. J Gen Virol 75 (1994) 301
14. Forman S.J., Zaia J.A., Clark B.R., et al. A 64000 Da matrix protein of human cytomegalovirus induces in vitro immune responses similar to those of whole viral antigen. J Immunol 134 (1985) 3391
15. He H., Rinaldo C.R., and Morel P.A. T cell proliferative responses to five human cytomegalovirus proteins in healthy seropositive individuals: implications for vaccine development. J Gen Virol 76 (1995) 1603
16. Landini M.P., Guan M.X., Jahn G., et al. Large-scale screening of human sera with cytomegalovirus recombinant antigens. J Clin Microbiol 28 (1990) 1375
17. Kraat Y.J., Stals F.S., Christiaans M.H.L., et al. IgM antibody detection for 38 (ppUL80a) and 150 (ppUL32) kDa proteins by immunoblotting: the earliest parameter for acute cytomegalovirus infection in renal transplant recipients. J Med Virol 48 (1996) 289
18. Greijer A.E., van de Crommert J.M., Stevens S.J., et al. Molecular fine-specificity analysis of antibody responses to human cytomegalovirus and design of novel synthetic-peptide-based serodiagnostic assays. J Clin Microbiol 37 (1999) 179
19. Essa S., Raghupathy R., Pacsa A.S., et al. Changes in cell mediated immunity in kidney transplant recipients with active CMV infection. FEMS Immunol Microbiol 18 (2002) 199
20. de Waal Malefyt R., Figdor C.G., Huijbens R., et al. Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes. Comparison with IL-4 and modulation by IFN-gamma or IL-10. J Immunol 1 (1993) 6370
21. Mosmann T.R., and Coffman R.L. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7 (1989) 145
22. Reusser P., Riddell S.R., Meyers J.D., et al. Cytotoxic T-lymphocyte response to cytomegalovirus after human allogeneic bone marrow transplantation: pattern of recovery and correlation with cytomegalovirus infection and disease. Blood 78 (1991) 1373